Which statements apply to generic substitution in Indiana?

In Indiana, the practice of generic substitution is governed by specific regulations that focus on the circumstances under which pharmacists can substitute a branded medication with a generic version. When looking at the statements provided in this question, we can understand why all of them are applicable and why the choice encompassing all is the correct option.

The first statement highlights that pharmacists are not permitted to substitute medications on veterinarian prescriptions. This acknowledges that veterinary prescriptions are treated differently in terms of substitution policies because they often involve different therapeutic considerations and regulatory frameworks.

The second statement addresses the requirement for pharmacists to substitute for Medicaid patients unless noted otherwise. This is grounded in the legislative intent to make medications more affordable for Medicaid beneficiaries. The law establishes a systematic approach to ensure that patients receive cost-effective treatment options through substitution unless a prescriber specifically prohibits it.

The third statement indicates that when a substitution occurs, both the original product name and the substituted generic name must appear on the medication label. This is crucial for patient safety and transparency, allowing patients and healthcare providers to be fully informed about the medication they are taking.

Collectively, these statements reflect the regulatory framework that governs generic substitution in Indiana, emphasizing both the protections in place for different patient populations and the importance of clear communication regarding medications. Consequently, option "